DiscGenics Employee Directory

Biotechnology ResearchUtah, United States11-50 Employees

DiscGenics is a privately held biotechnology research company focused on regenerative cell-based therapies intended to alleviate pain and restore function for patients with degenerative diseases of the spine. Its lead product candidate, IDCT, is an injectable, allogeneic cell therapy derived from intervertebral disc tissue, developed to address mild to moderate degenerative disc disease. The organization aims to offer a long-term therapeutic option for back pain by leveraging cells native to the spine to promote restoration rather than solely symptom management. Based in Salt Lake City, Utah, the company operates at a clinical stage within the biopharmaceutical sector and emphasizes an in-house, scalable cGMP manufacturing process for its therapies at its headquarters. DiscGenics serves patients suffering from degenerative spine conditions and positions itself in the regenerative medicine landscape by pursuing cell-based interventions that can be delivered non-surgically. A recent development indicates the company has expanded its facilities in Salt Lake City to support development and production timelines, maintaining in-house control over manufacturing and compliance.

Sign up for free to view info

Company overview Email format